TIGERMED Plans to Spend Up to RMB1B to Repurchase A Shares

TIGERMEDannounced plans to repurchase A shares worth between RMB500 million and RMB1 billion within 12 months. The repurchase will be funded through its own or self-raised funds via centralized bidding transactions. The shares will be used for A-share equity incentive schemes, employee share ownership plans, and to reduce registered capital, with a maximum repurchase price of RMB60 per share.

TIGERMED (03347.HK) +0.280 (+0.777%) Short selling $21.04M; Ratio 8.028% announced that it plans to use its own funds or self-raised funds within 12 months to repurchase part of its A shares through centralized bidding transactions. The repurchased shares will be used for the subsequent implementation of A-share equity incentive schemes or A-share employee share ownership plans, as well as to reduce the companys registered capital. The total repurchase amount will be no less than RMB500 million and no more than RMB1 billion, with the repurchase price not exceeding RMB60 per share. (ha/u)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-13 16:25.)